Novo Still Owes $3M Over Patent Use Code Row, Caraco Says

Law360, New York (August 29, 2012, 4:20 PM EDT) -- Generic-drug maker Caraco Pharmaceutical Laboratories Ltd. on Wednesday brought a contract suit against Novo Nordisk A/S in Michigan federal court, saying Novo hasn't made good on the $2.75 million it owes Caraco stemming from an earlier suit over drug patent use codes.

The instant case is based on a suit involving Caraco 's challenge to a use code — the description of patented methods for using a drug — listed by brand-name drug producer Novo, according to the complaint. Novo originally brought the underlying case under...
To view the full article, register now.




Case Information

Case Title

Caraco Pharmaceutical Laboratories, Ltd. et al v. Novo Nordisk A/S et al

Case Number



Michigan Eastern

Nature of Suit

Contract: Recovery/Enforcement


Avern Cohn

Date Filed

August 29, 2012

Law Firms


Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.